D
Dana P. Goldman
Researcher at University of Southern California
Publications - 381
Citations - 16877
Dana P. Goldman is an academic researcher from University of Southern California. The author has contributed to research in topics: Health care & Population. The author has an hindex of 62, co-authored 377 publications receiving 15247 citations. Previous affiliations of Dana P. Goldman include George Washington University & Dana Corporation.
Papers
More filters
Posted Content
The Effects of Relative Food Prices on Obesity -- Evidence from China: 1991-2006
Yang Lu,Dana P. Goldman +1 more
TL;DR: This paper explored the effects of relative food prices on body weight and body fat over time in China and found that changes in food consumption patterns induced by varying food prices can increase percentage body fat to risky levels even without substantial weight gain.
Journal Article
Bending the curve through health reform implementation
Joseph Antos,John Bertko,Michael E. Chernew,David M. Cutler,Francois de Brantes,Dana P. Goldman,Dana P. Goldman,Bob Kocher,Mark McClellan,Elizabeth A. McGlynn,Mark V. Pauly,Leonard D. Schaeffer,Stephen M. Shortell +12 more
TL;DR: A set of concrete, feasible steps that could achieve the goal of significantly slowing spending growth while improving the quality of care are released, but they need to be updated in light of the new Patient Protection and Affordable Care Act.
Journal ArticleDOI
Long-Term Health and Economic Value of Improved Mobility among Older Adults in the United States.
TL;DR: Interventions that improve mobility are likely to reduce long-run medical expenditures and nursing home utilization and increase employment and earnings between 2012 and 2030.
Journal ArticleDOI
Increased Medicare expenditures for physicians' services: what are the causes?
Melinda Beeuwkes Buntin,José J. Escarce,Dana P. Goldman,Hongjun Kan,Miriam Laugesen,Paul G. Shekelle +5 more
TL;DR: The per capita volume and intensity of physicians' services used by Medicare beneficiaries increased more than 30% between 1993 and 1998 and it was found that this increase was due to measurable changes in the demographic composition, places of residence, prevalence of health conditions, and managed care enrollment of beneficiaries.
Journal Article
Impact of specialty drugs on the use of other medical services.
TL;DR: Considering the high cost of many specialty drugs, health plans may rightly focus on making sure only patients who will most benefit receive them, but once such patients are identified, it makes little sense to limit coverage.